Related Experiment Video
Updated: Jun 28, 2026
05:56
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
The current management of septic shock
1Critical Care Medicine, St. Paul's Hospital, Vancouver, BC, Canada. jrussell@mrl.ubc.ca
Minerva Medica
|October 31, 2008
Summary
This review outlines the ABCDEF approach for managing septic shock, a condition with increasing incidence and high mortality. Early goal-directed therapy and prompt broad-spectrum antibiotics are crucial for improving survival in septic shock patients.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Immunology
Background:
- Septic shock incidence is rising, with mortality rates between 30% and 70%.
- Complex host-pathogen interactions drive septic shock, involving innate and adaptive immune responses.
- Septic shock is associated with a pro-coagulant state and significant organ dysfunction.
Purpose of the Study:
- To present a structured treatment approach (ABCDEF) for clinicians managing septic shock.
- To review current evidence on interventions for septic shock, including ventilation, resuscitation, antibiotics, and adjunctive therapies.
Main Methods:
- Review of existing literature and clinical guidelines on septic shock management.
- Discussion of specific therapeutic strategies: lung protective ventilation, early goal-directed therapy, fluid resuscitation, and antibiotic timing.
- Evaluation of evidence for adjunctive treatments like activated protein C, vasopressin, corticosteroids, insulin therapy, and renal support.
Main Results:
- Lung protective ventilation and early goal-directed therapy are recommended.
- Intravenous broad-spectrum antibiotics should be administered within one hour.
- Evidence for activated protein C shows mortality reduction in high-risk patients, but further trials are needed. Vasopressin and norepinephrine have similar mortality outcomes. Corticosteroids (hydrocortisone +/- fludrocortisone) show conflicting results on mortality. Intensive insulin therapy and intensive renal support do not consistently improve outcomes.
Conclusions:
- The ABCDEF approach provides a systematic framework for septic shock management.
- Prompt and appropriate interventions, including resuscitation and antibiotics, are vital.
- The role of adjunctive therapies requires careful consideration based on current evidence and patient-specific factors.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: